BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22278623)

  • 1. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
    Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
    Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
    Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
    Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertension.
    Magid DJ; Shetterly SM; Margolis KL; Tavel HM; O'Connor PJ; Selby JV; Ho PM
    Circ Cardiovasc Qual Outcomes; 2010 Sep; 3(5):453-8. PubMed ID: 20716714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological management of hypertension.
    Higgins B; Williams B;
    Clin Med (Lond); 2007 Dec; 7(6):612-6. PubMed ID: 18193713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cognitive function in patients with essential hypertension treated with lercanidipine.
    Tisaire-Sánchez J; Roma J; Camacho-Azcargorta I; Bueno-Gómez J; Mora-Maciá J; Navarro A
    Vasc Health Risk Manag; 2006; 2(4):491-8. PubMed ID: 17323604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Relationship Between Acne and Vasodilatory Medications in a Hospital-Wide Adult Population.
    Patel P; Wang J; Bitterman D; Zafar K; Kabakova M; Cohen M; Austin E; Jagdeo J
    J Drugs Dermatol; 2024 Jun; 23(6):446-449. PubMed ID: 38834225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers.
    Mehanna M; McDonough CW; Smith SM; Gong Y; Gums JG; Chapman AB; Johnson JA; Cooper-DeHoff RM
    Clin Transl Sci; 2024 May; 17(5):e13816. PubMed ID: 38747311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxins that affect the cardiovascular system.
    Thanacoody HK; Waring WS
    Clin Med (Lond); 2008 Feb; 8(1):92-5. PubMed ID: 18335680
    [No Abstract]   [Full Text] [Related]  

  • 10. Misuse of 'toxin'.
    Dayan AD
    Clin Med (Lond); 2008 Apr; 8(2):230. PubMed ID: 18478882
    [No Abstract]   [Full Text] [Related]  

  • 11. Are primary care practitioners in Barbados following hypertension guidelines? - a chart audit.
    Adams OP; Carter AO
    BMC Res Notes; 2010 Nov; 3():316. PubMed ID: 21092153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment of Arterial Hypertension.
    Brașoveanu AM; Cruce R; Mogoantă L; Cârlig V
    Curr Health Sci J; 2019; 45(4):358-365. PubMed ID: 32110437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.
    Rakugi H; Ogihara T; Umemoto S; Matsuzaki M; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
    Hypertens Res; 2013 Nov; 36(11):947-58. PubMed ID: 23864054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial.
    Umemoto S; Ogihara T; Rakugi H; Matsumoto M; Kitagawa K; Shimada K; Higaki J; Ito S; Suzuki H; Ohashi Y; Saruta T; Matsuzaki M;
    Hypertens Res; 2013 Dec; 36(12):1088-95. PubMed ID: 23985703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.
    Saruta T; Ogihara T; Saito I; Rakugi H; Shimamoto K; Matsuoka H; Teramukai S; Higaki J; Ito S; Shimada K
    Hypertens Res; 2015 Feb; 38(2):132-6. PubMed ID: 25253582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA; Basile J; Stapff M; Khan B; Zhou D
    J Clin Hypertens (Greenwich); 2012 Sep; 14(9):588-92. PubMed ID: 22947356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
    Ogawa H; Kim-Mitsuyama S; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K;
    Am J Med; 2012 Oct; 125(10):981-90. PubMed ID: 22503610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific differences in hypertension combination management and associated factors influencing treatment choice.
    Xiong J; Wang L; Yang C; Huang H; He B; Shen L; Su F
    J Clin Hypertens (Greenwich); 2023 Jun; 25(6):545-554. PubMed ID: 37196052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular outcomes of β-blocker-calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real-world retrospective study.
    Lin J; Guo Q; Lu Z; Chai D; Peng F; Lin J
    J Clin Hypertens (Greenwich); 2023 May; 25(5):440-452. PubMed ID: 37120711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.